Loading stock data…
PMV Pharmaceuticals (PMVP)
$1.29+0.10 (+8.40%)
Market ClosedLast close Jun 29
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PMV Pharmaceuticals, Inc. in the Healthcare sector is trading at $1.29 with a market capitalization of $57M. Wall Street consensus targets $4.33 (3 analysts), implying a +235.9% move over the next 12 months. The stock is currently 31% below its 52-week high of $1.88, remaining 0.8% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +235.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$19.02M↑ | -$19.24M↑ | -$22.52M↑ | -$22.88M↓ | -$21.56M |
| Net Income | -$18.04M | -$18.04M↑ | -$21.06M↑ | -$21.21M↓ | -$17.44M |
Peer Comparison
JNJUNHPFE
Fundamentals
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$57.33M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-89.06%
Volume
Today's trading volume
540,746
Recent News
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PMV Pharmaceuticals (PMVP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) is among the most popular penny stocks on Robinhood. TheFly reported on May 13 that Oppenheimer reduced its price target on PMVP from $6 to $5 while maintaining an Outperform rating after the company’s […]
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Staar Surgical (NASDAQ:STAA) shares rose 15.3% to $33.9 during Wednesday's after-market session. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today. Precision Optics Corp (NASDAQ:POCI) shares moved upwards by 15.21% to $5.3. The market value of their outstanding shares is at $49.6 million. As per the news, the Q3 earnings report came out today. Aquestive Therapeutics (NASDAQ:AQST) stock moved upwards by 13.55% to $4.69. The market value
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.